PMC:7228307 / 50603-50827
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 1006 | 53-57 | Gene | denotes | PD‐1 | Gene:5133 | |
| 1011 | 0-13 | Chemical | denotes | Pembrolizumab | MESH:C582435 | |
| 1012 | 15-24 | Chemical | denotes | nivolumab | MESH:D000077594 | |
| 1013 | 29-39 | Chemical | denotes | cemiplimab | MESH:C000627974 | |
| 1016 | 88-94 | Disease | denotes | cancer | MESH:D009369 | |
| 1017 | 187-192 | Mutation | denotes | S228P | rs1469294455 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T102 | 88-94 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T861 | 162-163 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T38212 | 0-13 | Chemical | denotes | Pembrolizumab | http://purl.obolibrary.org/obo/CHEBI_82976 |
| T9178 | 53-55 | Chemical | denotes | PD | http://purl.obolibrary.org/obo/CHEBI_74756 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes | pubann:has_HGVS_notation |
|---|---|---|---|---|---|---|
| 1006 | 53-57 | Gene | denotes | PD‐1 | Gene:5133 | |
| 1011 | 0-13 | Chemical | denotes | Pembrolizumab | MESH:C582435 | |
| 1012 | 15-24 | Chemical | denotes | nivolumab | MESH:D000077594 | |
| 1013 | 29-39 | Chemical | denotes | cemiplimab | MESH:C000627974 | |
| 1016 | 88-94 | Disease | denotes | cancer | MESH:D009369 | |
| 1017 | 187-192 | Mutation | denotes | S228P | rs1469294455 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T290 | 0-224 | Sentence | denotes | Pembrolizumab, nivolumab and cemiplimab are all anti‐PD‐1 antibodies currently used for cancer therapy and have been formatted on an IgG4 backbone95, 96, 97 with a stabilized core hinge (S228P) to prevent half‐IgG4 exchange. |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T646 | 53-57 | Protein | denotes | PD‐1 | https://www.uniprot.org/uniprot/Q7M4M5|https://www.uniprot.org/uniprot/Q6NZ54|https://www.uniprot.org/uniprot/Q3KQW2|https://www.uniprot.org/uniprot/P18621|https://www.uniprot.org/uniprot/J3QL51|https://www.uniprot.org/uniprot/B5ME31|https://www.uniprot.org/uniprot/B4E3C2|https://www.uniprot.org/uniprot/B2R4H3 |
LitCovid-sample-PD-GO-BP-0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T116 | 215-223 | http://purl.obolibrary.org/obo/GO_0015297 | denotes | exchange |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T43 | 88-94 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T39 | 88-94 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sample-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T116 | 215-223 | http://purl.obolibrary.org/obo/GO_0015297 | denotes | exchange |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T116 | 215-223 | http://purl.obolibrary.org/obo/GO_0015297 | denotes | exchange |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T290 | 0-224 | Sentence | denotes | Pembrolizumab, nivolumab and cemiplimab are all anti‐PD‐1 antibodies currently used for cancer therapy and have been formatted on an IgG4 backbone95, 96, 97 with a stabilized core hinge (S228P) to prevent half‐IgG4 exchange. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T39 | 88-94 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |